April 11, 2017
A key advisory committee of the Ministry of Health, Labor and Welfare (MHLW) will discuss on April 21 whether to recommend approval for Mundipharma’s injectable pralatrexate, a new molecular entity for the treatment of peripheral T-cell lymphoma. It has been...read more